GLOBAL GAUCHER DISEASE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Jul 2019 115

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.

Scope of the Report:
The technical barriers of Gaucher disease industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Sanofi, Shire, Actelion Pharma, Pfizer, etc.
There are 5 FDA-approved drugs for type I Gaucher’s disease, Cerezyme (imiglucerase) in 1993, Cerdelga (eliglustat) in 2014, VPRIV (velaglucerase alfa) for 2010, Elelyso (taliglucerase alfa) for 2012, and Zavesca (miglustat) in 2003. One KFDA-approved drugs for type I Gaucher’s disease Abcertin® for 2012.
The special provisions for orphan drugs for Gaucher disease is the key driver for the growth of this market. A few companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of Gaucher disease and their effectiveness will in turn promote growth in this market in the next few years.
The worldwide market for Gaucher Disease is expected to grow at a CAGR of roughly 2.7% over the next five years, will reach 1906.6 million US$ in 2024, from 1672 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Gaucher Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Sanofi
- Shire
- Actelion Pharma
- Pfizer (Protalix)
- ISU ABXIS

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Enzyme Replacement Therapy
- Substrate Reduction Therapy

Market Segment by Applications, can be divided into
- Non-neuronopathic Gaucher Disease
- Neuronopathic Gaucher Disease

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gaucher Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gaucher Disease, with price, sales, revenue and global market share of Gaucher Disease in 2017 and 2018.
Chapter 3, the Gaucher Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gaucher Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Gaucher Disease market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Gaucher Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Jul 19)

Scope of the Report: The worldwide market for Methoxy Polyethylene Glycol Reagent is expected to grow at a CAGR of roughly xx% over t...

(Jul 19)

Scope of the Report: The worldwide market for Legalized Cannabis is expected to grow at a CAGR of roughly xx% over the next five year...

(Jul 19)

It is a drug for treating pancreatic cancer with bile duct cancer. Scope of the Report: Pancreatic cancer is a disease...

(Jul 19)

Treatment of drugs for regulating rheumatic diseases Scope of the Report: Rheumatic diseases are a series of diseases ...

(Jul 19)

Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets. Sc...

(Jul 19)

Scope of the Report: The worldwide market for Amyloid Peptides is expected to grow at a CAGR of roughly xx% over the next five years,...

GLOBAL GAUCHER DISEASE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JULY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy